Roche Bid Raises Prospect Of Mass Tort Exodus From Philly

Law360, New York (September 25, 2012, 7:36 PM EDT) -- Hoffmann-La Roche Inc. is taking the extraordinary step of asking a Philadelphia judge to remove Accutane litigation from the court's notoriously crowded mass tort program, a bid that, if successful, could kickstart the ejection of torts against other companies from the system.

Roche filed a motion to rescind the litigation's status as a mass tort in Philadelphia's Complex Litigation Center on Sept. 10 and followed up with a reply brief on Friday. The drugmaker argues the suits, which allege the acne treatment Accutane caused plaintiffs' inflammatory...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.